Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

319 ARTÍCULOS , VIENDO DEL 121 AL 135

Blood-based biomarkers for early diagnosis of Alzheimer's disease: a current systematic review of diagnostic accuracy studies

Efe JJ, Anibor E, Pandey P, Sunday OG, Innocent DC, Anyakorah PE, Emmanuel OI.

BMC Neurol. 2026 Jun 5;26(1):502. doi: 10.1186/s12883-026-05046-6.

A systematic review and meta-analysis of metalloproteinases in patients with Alzheimer's disease and mild cognitive impairment

McNaugher G, McColgan L, Church M, McClean PL, Gibson DS, Murray EK, Coyle S, McGilligan V.

J Alzheimers Dis. 2026 Aug;112(3):1127-1142. doi: 10.1177/13872877261456729. Epub 2026 Jun 6.

Omics-driven strategies for identifying biomarkers in Alzheimer's disease

Khan Y, Rekha A, Ballal S, Maharana L, Maqbool M, Goyal K, Mishra R, Uniyal P, Alam P, Aljarba TM, Gupta G, Hussain MS.

Metab Brain Dis. 2026 Jun 6;41(1):128. doi: 10.1007/s11011-026-01873-1.

Plasma p-tau as a biomarker for the differential diagnosis of Alzheimer's disease: a systematic review and meta-analysis

Chai L, Zhan Y, Huang Y, Tian M, Zhao G, Ni J, Xiong X, Huang J, Lin B.

Alzheimers Res Ther. 2026 Jun 8;18(1):186. doi: 10.1186/s13195-026-02104-6.

Multimodal biomarker characterization of amnestic objective subtle cognitive decline in aging and preclinical Alzheimer's disease

López-Martos D, Cacciaglia R, Suárez-Calvet M, Salvadó G, Shekari M, González-Escalante A, Milà-Alomà M, Brugulat-Serrat A, Minguillon C, Tonietto M, Borroni E, Klein G, Quijano-Rubio C, Kollmorgen G, Zetterberg H, Blennow K, Gispert JD, Grau-Rivera O, Sánchez-Benavides G; ALFA study.

J Prev Alzheimers Dis. 2026 Aug;13(7):100612. doi: 10.1016/j.tjpad.2026.100612. Epub 2026 Jun 8.

Emerging Function of Prolactin-Inducible Protein-Is This Important Tear Protein Found in Alzheimer's Disease?

Chmiel J, Gawełczyk W, Soczyńska J, Leszek J.

Cells. 2026 Jun 3;15(11):1029. doi: 10.3390/cells15111029.

The role of YKL-40 in Alzheimer's disease pathology and drug targeting

Sha Y, Fu H, Lu K, Wang G, Wang Y.

PeerJ. 2026 Jun 8;14:e21361. doi: 10.7717/peerj.21361. eCollection 2026.

Impacts of menopausal hormone therapy on Alzheimer's disease biomarkers: A systematic review

Rodrigues AC, Valério FG, Moura CB, Da Silva AMP, Tudella GCN, Almeida SS, Gomes AC, Oliveira CEM, Apóstolos-Pereira SL, Santos DH.

J Alzheimers Dis. 2026 Aug;112(3):1143-1158. doi: 10.1177/13872877261456766. Epub 2026 Jun 16.

Contributions of the Alzheimer's Disease Neuroimaging Initiative to advancing AD research: a targeted review of recent publications

Veitch DP, Miller MJ, Kanoria S, Aisen PS, Beckett LA, Green RC, Harvey DJ, Jack CR Jr, Jagust W, Lee EB, Nho K, Nosheny R, Okonkwo OC, Perrin RJ, Petersen RC, Mindt MR, Saykin AJ, Shaw LM, Toga AW, Tosun D, Landau SM, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2026 Jun;22(6):e71566. doi: 10.1002/alz.71566.

Alzheimer's Disease and MERC Dysfunction: Integrating Mechanisms, Biomarkers, and Therapeutic Strategies

Kashif M, Majumder D.

Mol Neurobiol. 2026 Jun 18;63(1):701. doi: 10.1007/s12035-026-06009-1.

Clinico-biological trajectories stratified by combined tau biomarkers in preclinical Alzheimer's disease

Labrador-Espinosa MA, Franzmeier N, Karagianni S, Moscoso A, Schöll M.

Alzheimers Res Ther. 2026 Jun 24;18(1):154. doi: 10.1186/s13195-026-02123-3.

Plasma Biomarkers for Alzheimer's Disease Across the Continuum: A Systematic Review of SIMOA-Based Studies

de Los Ángeles Fernández-Ceballos M, Prieto-González JM, Agís-Balboa RC.

Cell Mol Neurobiol. 2026 Jun 24;46(1):109. doi: 10.1007/s10571-026-01752-4.

Head-to-head comparison of neurodegeneration biomarkers across two analytical platforms in Alzheimer's disease

Kurz C, Hattenkofer D, Pihale-Haug M, Hufnagel A, Gürsel SÜ, Brendel M, Rauchmann BS, Levin J, Höglinger G, Perneczky R.

Aging Clin Exp Res. 2026 Jun 25;38(1):157. doi: 10.1007/s40520-026-03420-5.

Accelerated long-term forgetting and relevant biomarkers for early detection in preclinical Alzheimer's disease

Ohno M.

Neuroscience. 2026 Sep 11;611:124-133. doi: 10.1016/j.neuroscience.2026.06.020. Epub 2026 Jun 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias